Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IITerminatedMay 11, 2022Lansoprazole Delayed-Release Orally Disintegrating TabletsFailed Dissolution SpecificationsDr. Reddy's Laboratories, Inc. · D-0853-2022Class IITerminatedMay 11, 2022Pantoprazole Sodium Delayed-Release TabletsCGMP deviations: tablets crackingTorrent Pharma Inc · D-0852-2022Class IIOngoingMay 11, 2022Erythromycin Topical Gel USPCGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.McKesson Corporation dba McKesson Drug Company · D-0851-2022Class IIOngoingMay 11, 2022Betamethasone Dipropionate Ointment USPCGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.McKesson Corporation dba McKesson Drug Company · D-0850-2022Class IIOngoingMay 11, 2022Lidocaine Prilocaine Cream USPCGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.McKesson Corporation dba McKesson Drug Company · D-0849-2022Class IIOngoingMay 11, 2022Lidocaine Hydrochloride Topical Solution USP 4%CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.McKesson Corporation dba McKesson Drug Company · D-0848-2022Class IIOngoingMay 11, 2022Halobetasol Propionate Ointment 0.05% Net WtCGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.McKesson Corporation dba McKesson Drug Company · D-0847-2022Class IIITerminatedMay 11, 2022Lidocaine Hydrochloride Oral Topical SolutionFailed viscosity specification - product was below specificcationAkorn, Inc. · D-0846-2022Class IITerminatedMay 11, 2022alprazolam XR extended-release tabletsFailed Dissolution Specifications: low out-of-specification dissolution test results observed.Viatris Inc · D-0844-2022Class IITerminatedMay 11, 2022Losartan Potassium and Hydrochlorothiazide Tablets USPCGMP Deviations- AZIDO Impurity levels observed to be above acceptable limitsLupin Pharmaceuticals Inc. · D-0843-2022Class IITerminatedMay 11, 2022Losartan Potassium and Hydrochlorothiazide Tablets USPCGMP Deviations- AZIDO Impurity levels observed to be above acceptable limitsLupin Pharmaceuticals Inc. · D-0842-2022Class IITerminatedMay 11, 2022Losartan Potassium and Hydrochlorothiazide Tablets USPCGMP Deviations- AZIDO Impurity levels observed to be above acceptable limitsLupin Pharmaceuticals Inc. · D-0841-2022Class IITerminatedMay 11, 2022Losartan Potassium Tablets USPCGMP Deviations- AZIDO Impurity levels observed to be above acceptable limitsLupin Pharmaceuticals Inc. · D-0840-2022Class IITerminatedMay 11, 2022Losartan Potassium Tablets USPCGMP Deviations- AZIDO Impurity levels observed to be above acceptable limitsLupin Pharmaceuticals Inc. · D-0839-2022Class IITerminatedMay 11, 2022Losartan Potassium Tablets USPCGMP Deviations- AZIDO Impurity levels observed to be above acceptable limitsLupin Pharmaceuticals Inc. · D-0838-2022Class IITerminatedMay 11, 2022Losartan Potassium & Hydrochlorothiazide TabletsCGMP Deviations- AZIDO Impurity levels observed to be above acceptable limitsMacleods Pharma Usa Inc · D-0837-2022Class IITerminatedMay 11, 2022Losartan Potassium & Hydrochlorothiazide TabletsCGMP Deviations- AZIDO Impurity levels observed to be above acceptable limitsMacleods Pharma Usa Inc · D-0836-2022Class IITerminatedMay 11, 2022Losartan Potassium & Hydrochlorothiazide TabletsCGMP Deviations- AZIDO Impurity levels observed to be above acceptable limitsMacleods Pharma Usa Inc · D-0835-2022Class IITerminatedMay 11, 2022Losartan Potassium TabletsCGMP Deviations- AZIDO Impurity levels observed to be above acceptable limitsMacleods Pharma Usa Inc · D-0834-2022Class IITerminatedMay 11, 2022Losartan Potassium TabletsCGMP Deviations- AZIDO Impurity levels observed to be above acceptable limitsMacleods Pharma Usa Inc · D-0833-2022Class IITerminatedMay 11, 2022Losartan Potassium TabletsCGMP Deviations- AZIDO Impurity levels observed to be above acceptable limitsMacleods Pharma Usa Inc · D-0832-2022Class IITerminatedMay 11, 2022Vancomycin HCl 1.5 g in 0.9% Sodium ChlorideCGMP DeviationsSCA Pharmaceuticals · D-0831-2022Class IITerminatedMay 11, 2022Fentanyl 2mcg/ml and Bupivacaine 0.125% in 0.9% Sodium Chloride 100 mL bagsCGMP DeviationsSCA Pharmaceuticals · D-0830-2022Class IITerminatedMay 11, 2022Norepinephrine 8mg in 0.9% Sodium Chloride 250 mL bagCGMP DeviationsSCA Pharmaceuticals · D-0829-2022Class ITerminatedMay 4, 2022Insulin GlargineLabeling: Missing label on the vialMylan Pharmaceuticals Inc · D-0845-2022Class IITerminatedMay 4, 2022NAD+ Nicotinamide Adenine Dinucleotide Lyophilized powder for reconstitutionFailed Reconstitution timeOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0828-2022Class IITerminatedMay 4, 2022Sincalide. Lyophilized powder for reconstitution. 5 mcg per Multi-Dose vialCGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0827-2022Class IITerminatedMay 4, 2022Hydroxocobalamin B12CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0826-2022Class IITerminatedMay 4, 2022UltratestCGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0825-2022Class IITerminatedMay 4, 2022Testosterone Cypionate 200 mg/mLCGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0824-2022Class IITerminatedMay 4, 2022Testosterone Cypionate 200 mg/mLCGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0823-2022Class IITerminatedMay 4, 2022Phenylephrine 1 mg/mLCGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0822-2022Class IITerminatedMay 4, 2022Formula F2CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0821-2022Class IITerminatedMay 4, 2022T-50, Papaverine 8 mg/mL . Phentolamine 0.29 mg/mL . Alprostadil 2.9 mcg/mLCGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0820-2022Class IITerminatedMay 4, 2022PGE-3, Alprostadil 150 mcg/mLCGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0819-2022Class IITerminatedMay 4, 2022PGE-2, Alprostadil 80 mcg/mLCGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0818-2022Class IITerminatedMay 4, 2022PGE-1, Alprostadil 40 mcg/mLCGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0817-2022Class IITerminatedMay 4, 2022FA, Papaverine 20 mg/mL . Phentolamine 2 mg/mL . Alprostadil 20 mcg/mL . Atropine 0.2 mg/mLCGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0816-2022Class IITerminatedMay 4, 2022BIMIX-3, Papaverine 30 mg/mL . Phentolamine 3 mg/mLCGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0815-2022Class IITerminatedMay 4, 2022RE-2, Papaverine 30 mg/mL . Phentolamine 3 mg/mL . Alprostadil 300 mcg/mLCGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0814-2022

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.